Published in
Esmo Open, Esmo Open, 4(4), p. e000532, 2019
DOI: 10.1136/esmoopen-2019-000532
Links
Tools
A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer
Journal article published in 2019 by
Juan-Miguel Cejalvo 
,
Wolfgang Jacob ,
Tania Fleitas Kanonnikoff,
Enriqueta Felip,
Alejandro Navarro Mendivil,
Maria Martinez Garcia ,
Alvaro Taus Garcia,
Natasha Leighl,
Ulrik Lassen ,
Morten Mau-Soerensen,
Celine Adessi,
Francesca Michielin,
Ian James,
Maurizio Ceppi,
Max Hasmann
and other authors.
,
Wolfgang Jacob ,
Tania Fleitas Kanonnikoff,
Enriqueta Felip,
Alejandro Navarro Mendivil,
Maria Martinez Garcia ,
Alvaro Taus Garcia,
Natasha Leighl,
Ulrik Lassen ,
Morten Mau-Soerensen,
Celine Adessi,
Francesca Michielin,
Ian James,
Maurizio Ceppi,
Max Hasmann
and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 